ClinicalTrials.govpublic full text
A Study of YL201 in Combination With Other Anti-Cancer Therapies in Patients With Advanced Solid Tumors
thoracic neoplasms, lung diseases, small cell lung carcinoma, small cell lung cancer, antibody drug conjugate, yl201, atezolizumab, interventional, phase1, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 874095
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.